BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29291161)

  • 1. Nanotechnology-Based Strategies for Early Cancer Diagnosis Using Circulating Tumor Cells as a Liquid Biopsy.
    Huang Q; Wang Y; Chen X; Wang Y; Li Z; Du S; Wang L; Chen S
    Nanotheranostics; 2018; 2(1):21-41. PubMed ID: 29291161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of nanomaterials in circulating tumor cell isolation and analysis.
    Yoon HJ; Kozminsky M; Nagrath S
    ACS Nano; 2014 Mar; 8(3):1995-2017. PubMed ID: 24601556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology-Assisted Isolation and Analysis of Circulating Tumor Cells on Microfluidic Devices.
    Cheng J; Liu Y; Zhao Y; Zhang L; Zhang L; Mao H; Huang C
    Micromachines (Basel); 2020 Aug; 11(8):. PubMed ID: 32823926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in nanotechnology-based detection and separation of circulating tumor cells.
    Myung JH; Tam KA; Park SJ; Cha A; Hong S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):223-39. PubMed ID: 26296639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy.
    Siemer S; Wünsch D; Khamis A; Lu Q; Scherberich A; Filippi M; Krafft MP; Hagemann J; Weiss C; Ding GB; Stauber RH; Gribko A
    Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32098406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives.
    Gribko A; Künzel J; Wünsch D; Lu Q; Nagel SM; Knauer SK; Stauber RH; Ding GB
    Int J Nanomedicine; 2019; 14():4187-4209. PubMed ID: 31289440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in microfluidic technologies for circulating tumor cells: enrichment, single-cell analysis, and liquid biopsy for clinical applications.
    Pei H; Li L; Han Z; Wang Y; Tang B
    Lab Chip; 2020 Nov; 20(21):3854-3875. PubMed ID: 33107879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells.
    Chen JY; Chang YC
    Adv Exp Med Biol; 2017; 994():43-66. PubMed ID: 28560667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances of lab-on-a-chip in isolation, detection and post-processing of circulating tumour cells.
    Yu L; Ng SR; Xu Y; Dong H; Wang YJ; Li CM
    Lab Chip; 2013 Aug; 13(16):3163-82. PubMed ID: 23771017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
    Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
    Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterial-Based Immunocapture Platforms for the Recognition, Isolation, and Detection of Circulating Tumor Cells.
    Liu Y; Li R; Zhang L; Guo S
    Front Bioeng Biotechnol; 2022; 10():850241. PubMed ID: 35360401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights.
    Chemi F; Mohan S; Guevara T; Clipson A; Rothwell DG; Dive C
    Front Oncol; 2021; 11():672195. PubMed ID: 34026650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.
    Yaghoubi Naei V; Bordhan P; Mirakhorli F; Khorrami M; Shrestha J; Nazari H; Kulasinghe A; Ebrahimi Warkiani M
    Ther Adv Med Oncol; 2023; 15():17588359231192401. PubMed ID: 37692363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities.
    Habli Z; AlChamaa W; Saab R; Kadara H; Khraiche ML
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
    Onstenk W; Gratama JW; Foekens JA; Sleijfer S
    Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response.
    Liu J; Lian J; Chen Y; Zhao X; Du C; Xu Y; Hu H; Rao H; Hong X
    Front Genet; 2021; 12():734595. PubMed ID: 34512735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.
    Stoecklein NH; Fischer JC; Niederacher D; Terstappen LW
    Expert Rev Mol Diagn; 2016; 16(2):147-64. PubMed ID: 26587751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.